BiopharmaTrend: Where Tech Meets Bio

BioPharmaTrend

Latest News

Basetwo Raises $11.5M for AI-Driven, First-Principles Pharmaceutical …

Basetwo Raises $11.5M for AI-Driven, First-Principles Pharmaceutical Manufacturing Optimization

Basetwo, an AI platform for manufacturing engineers, has raised $11.5 million in Series A funding. The funding will support the development of Basetwo’s Physics AI … Read More

Insilico Medicine Doses First Patient With AI-Designed …

Insilico Medicine Doses First Patient With AI-Designed Pan-TEAD Inhibitor

Insilico Medicine, a clinical-stage biotechnology company leveraging generative AI for drug discovery, has dosed the first patient in its global Phase I trial of ISM6331, … Read More

Advarra Launches Study Collaboration Solution to Accelerate …

Advarra Launches Study Collaboration Solution to Accelerate Clinical Trial Startup

Advarra, a provider of regulatory review solutions and clinical research technology, has introduced its Study Collaboration solution, designed to streamline site activation workflows, improve stakeholder … Read More

RyboDyn Uncovers Dark Proteome, Secures $4M Pre-Seed for Cancer Immunotherapy

Icelandic Biotech Raises €26.5M for Clinical-Stage Dementia and Skin Disease Treatments

Tempus Announces National Launch of AI-Powered Personal Health Assistant

Study: Trust in Scientists Post-Pandemic Remains High, but Public Wants More Engagement

Mayo Clinic Partners with Microsoft and Cerebras on Radiology and Genomics Foundation Models

Longevity Company Rubedo Announces Phase 1 Trials for GPX4 Modulator Targeting Aging Cells and Surrounding Tissues

Read latest news ›››

Latest Insights

Reviving the Brain’s Waste Disposal System with …

by Andrii Buvailo, PhD

Reviving the Brain’s Waste Disposal System with a Labor-Inducing Drug

New research from the University of Rochester demonstrates the potential of a drug commonly used to induce labor in restoring the brain's waste disposal system, … Read More

The AI-driven Development Journey of ISM5411, a …

by Andrii Buvailo, PhD

The AI-driven Development Journey of ISM5411, a Potential Breakthrough Treatment for Inflammatory Bowel Disease

Inflammatory Bowel Disease (IBD), a chronic and debilitating autoimmune disorder that includes ulcerative colitis and Crohn’s disease, impacts millions of lives globally. Characterized by chronic … Read More

Combination Therapies May Be the Future of Oncology – How Can We Navigate Development Challenges Today?

by Andreas Dreps, Bea Mann, PhD

The Future of Advanced Therapeutics: Opportunities and Challenges

by Sai Bhamidipati

What CROs Cite as Their Top Clinical Trial Challenges and How They Plan to Overcome Them in 2025

by Megan Deegan

21 Life Science Marketplaces to Try in 2024

by Andrii Buvailo

FTI Survey: Healthcare & Life Sciences Optimism, M&A and AI to Drive 2025 Growth

by BiopharmaTrend

Chemistry CROs at a Crossroads: How SpiroChem Is Adapting to Market Shifts in 2025 and Beyond

by Thomas Fessard

Legal and Governance Considerations in AI for Drug Discovery: New Paradigms and 2025 Outlook

by Nikhil Pradhan

The AI-driven Development Journey of ISM5411, a Potential Breakthrough Treatment for Inflammatory Bowel Disease

by Andrii Buvailo, PhD

Read all insights ›››

From Our Partners

Read All ›››

This AI Startup Joins Forces With NVIDIA's …

Sponsored by RECEPTOR.AI

This AI Startup Joins Forces With NVIDIA's BioNeMo to Boost Drug Discovery

AI Breaches the Barrier Towards Better CNS …

Sponsored by Lantern Pharma

AI Breaches the Barrier Towards Better CNS Drug Discovery

How AI Empowers Biomarker-Driven Clinical Trials

Sponsored by Lantern Pharma

How AI Empowers Biomarker-Driven Clinical Trials

Beyond Traditional Clinical Trials: MEDSIR’s Adaptive Designs …

Sponsored by MEDSIR

Beyond Traditional Clinical Trials: MEDSIR’s Adaptive Designs and Precision Medicine in Oncology

Partner Events

View all events ›››

London Biotechnology Show 2025

London Biotechnology Show 2025

Event Date: June 18, 2025 - June 19, 2025

Location: United Kingdom (Hall N7 & N8 Bett Global, Excel London, Royal Victoria Dock, 1 Western Gateway, London, UK, England, GB, E16 1XL)

Website: Link

22nd BioPharma Drug Discovery Nexus Conference Belgium

22nd BioPharma Drug Discovery Nexus Conference Belgium

Event Date: April 29, 2026 - April 29, 2026

Location: Belgium (Brussels, Holiday Inn)

Website: Link

BIOCHINA 2025

Event Date: March 13, 2025 - March 15, 2025

Location: China (Suzhou International Expo Center)

Website: Link

Global Clinical Trials Connect 2025

Global Clinical Trials Connect 2025

Event Date: May 28, 2025 - May 29, 2025

Location: United Kingdom (London)

Website: Link

22nd BioPharma Clinical Trials Nexus Conference

22nd BioPharma Clinical Trials Nexus Conference

Event Date: March 13, 2025 - March 14, 2025

Location: Switzerland (Basel)

Website: Link

The 12th Aging Research & Drug Discovery Meeting The 11th Aging Research & Drug Discovery Meeting

The 12th Aging Research & Drug Discovery Meeting The 11th Aging Research & Drug Discovery Meeting

Event Date: Aug. 25, 2025 - Aug. 29, 2025

Location: Denmark (Ceremonial Hall, University of Copenhagen)

Website: Link

Case Studies

Read All ›››

ArtiDock from Receptor.AI: Next-generation AI Docking That …

Sponsored by RECEPTOR.AI

ArtiDock from Receptor.AI: Next-generation AI Docking That Beats DiffDock and AlphaFold-latest

Revolutionizing Clinical Trials: How AI and Automation …

Sponsored by Trialize

Revolutionizing Clinical Trials: How AI and Automation Reduced Study Build Time from Months to Days

Bioz Badges — Advanced Data-Widgets for Confident …

Sponsored by Bioz

Bioz Badges — Advanced Data-Widgets for Confident E-commerce

Identifying High Impact Tissue Sparing E3 Ligases …

Sponsored by Kymera Therapeutics

Identifying High Impact Tissue Sparing E3 Ligases and Their Binders

AI Becomes a Drop-in Replacement for Docking

Sponsored by RECEPTOR.AI

AI Becomes a Drop-in Replacement for Docking

How Astellas Pharma Achieves R&D Operational Excellence …

Sponsored by Science Exchange

How Astellas Pharma Achieves R&D Operational Excellence with Science Exchange

QUAISAR Computational Platform for Designing Targeted Protein …

Sponsored by Roivant Sciences

QUAISAR Computational Platform for Designing Targeted Protein Degraders

Cyclica's Chemical Probes for DCAF1

Sponsored by Cyclica

Cyclica's Chemical Probes for DCAF1

Interviews

Read All ›››

The Synergistic Potential of AI and Synthetic …

The Synergistic Potential of AI and Synthetic Biology: Interview with S&P Global’s Miriam Fernández

Beyond Traditional Clinical Trials: MEDSIR’s Adaptive Designs …

Beyond Traditional Clinical Trials: MEDSIR’s Adaptive Designs and Precision Medicine in Oncology

[Interview] How D-Wave Brings Quantum Computing Into …

[Interview] How D-Wave Brings Quantum Computing Into Biology

Merging AI and Quantum Computing To Boost …

Merging AI and Quantum Computing To Boost Drug Discovery

Most Read

The Explosion of Therapeutic Modalities: Small Molecules, …

The Explosion of Therapeutic Modalities: Small Molecules, Biologics, and Everything in Between

13 Publicly Traded Biotechs Utilizing AI-based Research …

13 Publicly Traded Biotechs Utilizing AI-based Research Platforms (+ 2 Upcoming Public Debuts)

21 Life Science Marketplaces to Try in …

21 Life Science Marketplaces to Try in 2024

5 AI-Powered Companies Transforming the Future of …

5 AI-Powered Companies Transforming the Future of Fertility Care